We reiterate our BUY rating, and lower our fair value estimate from $53.01 to $43.86/share, based on the average of our DCF and comparables valuations. We believe ZEPP’s strong balance sheet, broader product lineup, and higher-priced products offer meaningful upside, despite near-term earnings pressure and negative sector sentiment.

Disclosure: Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports. This fee creates a potential conflict of interest which readers should consider. See last page for other important disclosures, rating, and risk definitions.
All figures in US$ unless otherwise specified.
Price and Volume (1-year)
| YTD | 12M | |
|---|---|---|
| ZEPP | -86% | -93% |
| NYSE | 8% | 10% |
| Index* | 38% | 8% |
| Key Financial Data ($, 000s; except EPS) YE: Dec 31st |
2023 | 2024 | 2025 | 2026E | 2027E |
|---|---|---|---|---|---|
| Cash | $140,469 | $110,735 | $112,933 | $94,178 | $80,642 |
| Working Capital | $161,621 | $56,197 | $6,681 | -$41,364 | -$53,484 |
| Total Assets | $635,519 | $528,593 | $564,836 | $558,318 | $557,282 |
| LT-Debt | $120,020 | $75,241 | $59,475 | $40,043 | $40,043 |
| Revenue | $351,459 | $182,603 | $258,897 | $304,213 | $323,982 |
| Gross Profit | $92,646 | $70,234 | $99,190 | $118,643 | $126,353 |
| Net Income | -$29,877 | -$75,733 | -$40,068 | -$26,192 | -$9,804 |
| EPS | -$0.12 | -$0.29 | -$0.16 | -$0.10 | -$0.04 |
In Q2, Huawei overtook Apple as the world’s largest smartwatch brand. Zepp ranks seventh globally, maintaining its position. For context, Huawei ships ~35M units annually; Zepp ships ~3-4M.
Zepp shipments fell 14% YoY in Q2, reflecting a 4% YoY decline in global smartwatch unit sales, and temporary supply constraints affecting select products; management expects supply to normalize by Q4.
Revenue: Up 7% YoY, 3% below our forecast, driven by higher selling prices (up 25% YoY), partially offset by lower shipments (down 14% YoY).
| Segmented Revenue | Q1-2025 | Q1-2026 | YoY | Q2-2025 (US$) | Q2-2026 (US$) | YoY | H1-2025 (US$) | H1-2026 (US$) | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Self-branded products (000s) | $38,537 | $51,547 | 34% | $59,406 | $63,525 | 7% | $97,943 | $115,072 | 17% |
| Xiaomi wearable products (000s) | - | - | n/a | - | - | N/A | - | - | N/A |
| Total (000s) | $38,537 | $51,547 | 34% | $59,406 | $63,525 | 7% | $97,943 | $115,072 | 17% |
| % Self-branded products | 100% | 100% | 100% | 100% | 100% | 100% | |||
| % Xiaomi wearable products | 0% | 0% | 0% | 0% | 0% | 0% | |||
| Self-branded units shipped (M) | 0.5 | 0.6 | 20% | 0.7 | 0.6 | -14% | 1.2 | 1.2 | 0% |
| Xiaomi units shipped (M) | - | - | n/a | - | - | N/A | - | - | N/A |
| Total | 0.5 | 0.6 | 20% | 0.7 | 0.6 | -14% | 1.2 | 1.2 | 0% |
| Price per Self-branded unit | $77 | $86 | 11% | $85 | $106 | 25% | $82 | $96 | 17% |
| Price per Xiaomi unit | - | - | n/a | - | - | N/A | - | - | N/A |
| Average | $77 | $86 | 11% | $85 | $106 | 25% | $82 | $96 | 17% |
In line with industry standards, Zepp retains 70% of the retail price of its products as revenue, while retailers and distributors keep the remaining 30%; Zepp does not disclose segmented results; Smart wristbands, and watches, constitute 90%+ of revenue; Self-Branded Products - Europe & the Middle East account for 50% of sales, followed by North America (15-20%), China (10%), and the rest of the world (15-30%); Xiaomi owns 20% of Zepp’s outstanding shares.
Gross Margins: Up 1.2 pp YoY, in line with our estimate, and the wearable tech sector (38%), but above the consumer electronics sector (26%).
| Margins | Q1-2025 | Q1-2026 | Q2-2025 | Q2-2026 | H1-2025 | H1-2026 | Sector |
|---|---|---|---|---|---|---|---|
| Gross | 37.3% | 37.7% | 36.2% | 37.4% | 36.6% | 37.5% | 25.7% |
| EBITDA | -46.0% | -33.4% | -9% | -19% | -23.6% | -25.2% | 8.7% |
| EBIT | -47.7% | -34.3% | -10% | -19% | -25.0% | -26.1% | 5.1% |
| Net | -51.2% | -38.1% | -13% | -18% | -28.1% | -26.9% | 0.8% |
| Expenses as % of Revenue | Q1-2025 | Q1-2026 | Q2-2025 | Q2-2026 | H1-2025 | H1-2026 |
|---|---|---|---|---|---|---|
| G&A | 16.9% | 14.3% | 7.4% | 9.8% | 11.1% | 11.8% |
| R&D | 30.5% | 24.5% | 17.6% | 17.4% | 22.7% | 20.6% |
| Selling & Marketing | 35.9% | 32.3% | 20.3% | 28.8% | 26.4% | 30.4% |
We believe new higher-priced product launches should support margin growth in 2026. However, operating expenses were up 32% YoY, 11% above our forecast, driven by prepaid marketing, new product launch campaigns, and sponsorships for new athletes; with most major product launches for the year completed, OPEX should decline in coming quarters.
EPS: Declined YoY from ($0.03) to ($0.04), below our forecast of ($0.03), primarily due to higher operating expenses. Net Cash & Investments: $140M ($9.71/share) vs. the current share price of $3.91, implying the stock trades well below liquid asset value.
| Liquidity and Capital Structure | 2023 | 2024 | 2025 | Q1-2026 | Q2-2026 | Sector |
|---|---|---|---|---|---|---|
| Cash | 140,469 | 110,735 | 112,933 | 103,151 | 106,269 | |
| Working Capital | 161,621 | 56,197 | 6,681 | -35,000 | -31,864 | |
| Current Ratio | 2.04 | 1.29 | 1.02 | 0.88 | 0.90 | 1.30 |
| Total Debt | 188,701 | 178,773 | 226,928 | 238,132 | 244,911 | |
| LT-Debt | 120,020 | 75,241 | 59,475 | 40,043 | 56,397 | |
| Total Debt / Capital | 35% | 41% | 51% | 55% | 57% | 29% |
| LT Debt / Capital | 22% | 17% | 13% | 9% | 13% | 18% |
Global smartwatch shipments fell 4% YoY in Q2, and are expected to decline 2% in 2026, due to longer replacement cycles.
Market Share and Growth
| 2023 | 2023 | 2024 | 2025 | 2026E | |
|---|---|---|---|---|---|
| Global Smartwatch Shipments (Millions) | 161 | 161 | 154 | 164 | 160 |
| Zepp's Market Share (self-branded) | 2.6% | 2.6% | 1.5% | 1.8% | 2.0% |
| Zepp's Growth (self-branded) | -33.3% | -33.3% | -45.2% | 30.4% | 5.7% |
| Global Growth | 8.1% | 8.1% | -4.3% | 6.5% | -2.4% |
Zepp products accounted for 1.8% of global smartwatch shipments in 2025; we anticipate this increasing to 2.0% in 2026, driven by a broader product lineup.
| US$, 000s (except EPS) |
2026E (Old) | 2026E (New) | 2027E (Old) | 2027E (New) |
|---|---|---|---|---|
| Revenue | $313,164 | $304,213 | $356,359 | $323,982 |
| EBITDA | -$783 | -$18,253 | $22,451 | -$1,620 |
| Net Profit | -$8,722 | -$26,192 | $12,127 | -$9,804 |
| EPS | -$0.03 | -$0.10 | $0.05 | -$0.04 |
Zepp’s Q3 revenue guidance implies a 4%–10% YoY decline, below our forecast, due to market weakness, and supply constraints expected to ease by Q4. As a result, we are lowering our revenue and EPS forecasts. We now expect profitability in 2028 vs. 2027 previously. Our DCF valuation declined from $40 to $32/share.
| DCF Model (US$, 000s) | 2026E | 2027E | 2030E | Terminal |
|---|---|---|---|---|
| EBIT (1-tax) | (15,249) | (2,852) | 52,988 | |
| Non-Cash Expenses | 4,579 | 4,683 | 5,027 | |
| Change in Working Capital | (1,347) | (1,414) | (1,637) | |
| Cash from Operations | (12,017) | 417 | 56,378 | |
| CAPEX | (7,000) | (7,000) | (7,000) | |
| Free Cash Flow | (19,017) | (6,583) | 49,378 | |
| Present Value | (15,716) | (4,946) | 27,872 | 410,124 |
| Discount Rate | 10.0% | |||
| Terminal Growth | 3.0% | |||
| Present Value (US$) | $463,142,239 | |||
| Cash - Debt (US$) | $51,040,250 | |||
| Fair Value (US$) | $514,182,489 | |||
| Shares O/S | 15,845,828 | |||
| Value per Share (US$) | $32.45 | |||
Sector EV/forward revenue is down 7% since our previous report in July 2026. ZEPP remains undervalued, trading at just 0.10x forward revenue (previously 0.14x), well below the sector average of 3.49x (previously 3.74x). Applying 3.49x to our 2026 revenue forecast for Zepp, we arrived at a comparables valuation of $55/share (previously $66/share).
| Zepp vs Major Wearable Tech Companies | MCAP ($M) | Revenue (US$M) | Gross Margin | EV/R (f) |
|---|---|---|---|---|
| Apple | $4,858,257 | $466,823 | 49% | 10.04 |
| Samsung | $1,309,501 | $356,124 | 58% | 2.18 |
| Sony | $138,294 | $81,846 | 32% | 1.72 |
| Xiaomi | $78,319 | $65,239 | 21% | 1.05 |
| Garmin | $55,063 | $7,671 | 60% | 6.29 |
| iFlytek | $13,334 | $4,142 | 42% | 3.11 |
| Andon Health | $3,779 | $169 | 62% | N/A |
| Ambarella | $3,013 | $418 | 59% | 6.24 |
| Kopin | $874 | $44 | 20% | 14.03 |
| Cosonic Intelligent | $653 | $335 | 11% | 1.80 |
| Vuzix | $252 | $6 | n/a | n/a |
| GoPro | $245 | $569 | 28% | 0.56 |
| Immersion | $241 | $1,733 | 22% | n/a |
| QuickLogic | $213 | $16 | 27% | 8.49 |
| Zepp Health | $62 | $304 | 38% | 0.10 |
| Average | 38% | 3.49 |
Oura, a leading smart-ring company, recently postponed its IPO amid market uncertainty, and investor concerns over valuation. We believe declining smartwatch sales may have also contributed to caution toward the wearables sector.
We reiterate our BUY rating, and lower our fair value estimate from $53.01 to $43.86/share, based on the average of our DCF and comparables valuations. We believe ZEPP’s strong balance sheet, broader product lineup, and higher-priced products offer meaningful upside, despite near-term earnings pressure and negative sector sentiment. ZEPP trades at a 97% discount to the sector on forward revenue, offering an attractive entry point.
We are maintaining our risk rating of 3 (Average).
We believe the company is exposed to the following key risks (not exhaustive):
| INCOME STATEMENTS (000s) YE: December 31st |
2023 | 2024 | 2025 | 2026E | 2027E |
|---|---|---|---|---|---|
| Revenue | $352,860 | $182,603 | $258,897 | $304,213 | $323,982 |
| Cost of Sales | $260,502 | $112,369 | $159,707 | $185,570 | $197,629 |
| Gross Profit | $92,358 | $70,234 | $99,190 | $118,643 | $126,353 |
| G&A | $26,778 | $24,854 | $29,273 | $33,463 | $34,018 |
| R&D | $49,218 | $43,892 | $43,008 | $42,590 | $38,878 |
| Selling & Marketing | $44,527 | $46,471 | $53,829 | $60,843 | $55,077 |
| EBITDA | -$28,165 | -$44,983 | -$26,920 | -$18,253 | -$1,620 |
| D&A | $2,285 | $2,267 | $2,310 | $2,079 | $2,183 |
| EBIT | -$30,450 | -$47,250 | -$29,230 | -$20,332 | -$3,803 |
| Interest | $6,752 | $5,552 | $5,697 | $5,860 | $6,001 |
| EBT | -$37,202 | -$52,802 | -$34,927 | -$26,192 | -$9,804 |
| Tax | -$2,430 | $13,693 | $2,537 | ||
| Unusual/Non-recurring expense | -$3,686 | $9,313 | $2,604 | ||
| Non-controlling interest | -$66 | -$75 | |||
| Net Income | -$31,020 | -$75,733 | -$40,068 | -$26,192 | -$9,804 |
| EPS | -$0.13 | -$0.29 | -$0.16 | -$0.10 | -$0.04 |
| CASH FLOW STATEMENTS (000s) YE: December 31st |
2026E | 2027E |
|---|---|---|
| Operating Activities | ||
| Net income | -$26,192 | -$9,804 |
| Depreciation & amortization | $2,079 | $2,183 |
| Share-based compensation | $2,500 | $2,500 |
| Items Not Involving Cash | -$21,613 | -$5,121 |
| Changes in WC | -$1,347 | -$1,414 |
| Cash From Operations | -$22,959 | -$6,535 |
| Investing activities | ||
| PP&E / Intangible assets | -$7,000 | -$7,000 |
| Others | ||
| Cash Used in Investing Activities | -$7,000 | -$7,000 |
| Financing activities | ||
| Debt | $11,204 | - |
| Cash Provided by Financing Activities | $11,204 | - |
| BALANCE SHEETS (000s) YE: December 31st |
2023 | 2024 | 2025 | 2026E | 2027E |
|---|---|---|---|---|---|
| Assets | |||||
| Cash | $140,469 | $110,735 | $112,933 | $94,178 | $80,642 |
| Trade & receivables | $69,332 | $65,628 | $73,573 | $77,252 | $81,114 |
| Short term investments | $5,153 | $997 | |||
| Inventory | $84,887 | $56,789 | $72,756 | $76,394 | $80,213 |
| Other current assets | $16,891 | $17,415 | $34,263 | $34,263 | $34,263 |
| Current Assets | $316,732 | $251,564 | $293,525 | $282,086 | $276,233 |
| PP&E & intangible assets | $18,797 | $13,989 | $19,273 | $24,194 | $29,011 |
| Long term investments | $238,540 | $225,910 | $220,047 | $220,047 | $220,047 |
| Other long term assets | $61,450 | $37,130 | $31,991 | $31,991 | $31,991 |
| Total Assets | $635,519 | $528,593 | $564,836 | $558,318 | $557,282 |
| Liabilities & Shareholders' Equity | |||||
| Payables and accrued liabilities | $86,430 | $91,835 | $119,391 | $125,361 | $131,629 |
| Debt | $68,681 | $103,532 | $167,453 | $198,089 | $198,089 |
| Current Liabilities | $155,111 | $195,367 | $286,844 | $323,450 | $329,718 |
| Borrowings | $120,020 | $75,241 | $59,475 | $40,043 | $40,043 |
| Lease liabilities | $3,197 | $2,007 | $1,102 | $1,102 | $1,102 |
| Tax liabilities & Other | $4,439 | $3,250 | $2,882 | $2,882 | $2,882 |
| Total Liabilities | $282,767 | $275,865 | $350,303 | $367,477 | $373,745 |
| Equity | $352,752 | $252,728 | $214,533 | $190,841 | $183,538 |
| Total Liabilities and SE | $635,519 | $528,593 | $564,836 | $558,318 | $557,282 |
Sid Rajeev, B.Tech, MBA, CFA — Head of Research, Fundamental Research Corp.
The full report — the designed PDF with all charts and the complete disclosure — remains available as published, free of charge with a free account. This page is the same analysis in the form a search engine, an AI assistant and a phone screen can read.
Buy – Fair value is 12% above the current market price; or risk and reward is favorable
Hold – Fair value is between 5% to 12% above the current market price
Sell – Fair value is 5% above, or less, than the current market value; or risk and reward is unfavorable
Suspended or Rating N/A— Coverage and ratings suspended until more information can be obtained from the company regarding recent events.
1 (Low Risk) - The company operates in an industry where it has a strong position (for example a monopoly, high market share etc.) or operates in a regulated industry. The future outlook is stable or positive for the industry. The company generates positive free cash flow and has a history of profitability. The capital structure is conservative with little or no debt.
2 (Below Average Risk) - The company operates in an industry where the fundamentals and outlook are positive. The industry and company are relatively less sensitive to systematic risk than companies with a Risk Rating of 3. The company has a history of profitability and has demonstrated its ability to generate positive free cash flows (though current free cash flow may be negative due to capital investment). The company’s capital structure is conservative with little to modest use of debt.
3 (Average Risk) - The company operates in an industry that has average sensitivity to systematic risk. The industry may be cyclical. Profits and cash flow are sensitive to economic factors although the company has demonstrated its ability to generate positive earnings and cash flow. Debt use is in line with industry averages, and coverage ratios are sufficient.
4 (Speculative) - The company has little or no history of generating earnings or cash flow. Debt use is higher. These companies may be in start-up mode or in a turnaround situation. These companies should be considered speculative.
5 (Highly Speculative) - The company has no history of generating earnings or cash flow. They may operate in a new industry with new, and unproven products. Products may be at the development stage, testing, or seeking regulatory approval. These companies may run into liquidity issues and may rely on external funding. These stocks are considered highly speculative.
Definition of FRC’s Fair Value Estimate – Our fair value estimate is the theoretical value of the company’s equity using widely accepted methods of valuation such as discount cash flow or comparables. IT IS NOT A TARGET PRICE or PREDICTION OF THE FUTURE STOCK PRICE.
Analyst Certification: The views expressed in this report accurately reflect the personal views of the analyst, and no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation or views expressed.
Any “forward looking statements” are our best estimates and opinions based upon information that is publicly available and that we believe to be correct, but we have not independently verified with respect to truth or correctness. There is no guarantee that our forecasts will materialize. Actual results will likely vary. The analyst and Fundamental Research Corp. “FRC” do not own any shares of the subject company, do not make a market or offer shares for sale of the subject company, and do not have any investment banking business with the subject company. Fees ranging between $20,000 and $30,000 have been paid to FRC by Zepp Health to commission this report, research coverage, and distribution of reports. This fee creates a potential conflict of interest which readers should consider. FRC takes steps to mitigate conflicts including setting fees in advance and utilizing analysts who must abide by CFA Institute Code of Ethics and Standards of Professional Conduct. Additionally, analysts may not trade in any security under coverage. Our full editorial control of all research, timing of release of the reports, and release of liability for negative reports are protected contractually. The issuer has agreed to a minimum coverage term and coverage cannot be unilaterally terminated. Distribution procedure: our reports are distributed first to our web-based subscribers on the date shown on this report then made available to delayed access users through various other channels for a limited time.
The distribution of FRC’s ratings are as follows: BUY (76%), HOLD (2%), SELL / SUSPEND (22%).
This report contains "forward looking" statements. Forward-looking statements regarding the Company and/or stock’s performance inherently involve risks and uncertainties that could cause actual results to differ from such forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products/services in the marketplace; acceptance in the marketplace of the Company's new product lines/services; competitive factors; new product/service introductions by others; technological changes; dependence on suppliers; systematic market risks and other risks discussed in the Company's periodic report filings, including interim reports, annual reports, and annual information forms filed with the various securities regulators. By making these forward-looking statements, Fundamental Research Corp. and the analyst/author of this report undertakes no obligation to update these statements for revisions or changes after the date of this report. A report initiating coverage will most often be updated quarterly while a report issuing a rating may have no further or less frequent updates because the subject company is likely to be in earlier stages where nothing material may occur quarter to quarter.
Fundamental Research Corp DOES NOT MAKE ANY WARRANTIES, EXPRESSED OR IMPLIED, AS TO RESULTS TO BE OBTAINED FROM USING THIS INFORMATION AND MAKES NO EXPRESS OR IMPLIED WARRANTIES OR FITNESS FOR A PARTICULAR USE. ANYONE USING THIS REPORT ASSUMES FULL RESPONSIBILITY FOR WHATEVER RESULTS THEY OBTAIN FROM WHATEVER USE THE INFORMATION WAS PUT TO. ALWAYS TALK TO YOUR FINANCIAL ADVISOR BEFORE YOU INVEST. WHETHER A STOCK SHOULD BE INCLUDED IN A PORTFOLIO DEPENDS ON ONE’S RISK TOLERANCE, OBJECTIVES, SITUATION, RETURN ON OTHER ASSETS, ETC. ONLY YOUR INVESTMENT ADVISOR WHO KNOWS YOUR UNIQUE CIRCUMSTANCES CAN MAKE A PROPER RECOMMENDATION AS TO THE MERIT OF ANY PARTICULAR SECURITY FOR INCLUSION IN YOUR PORTFOLIO. This REPORT is solely for informative purposes and is not a solicitation or an offer to buy or sell any security. It is not intended as being a complete description of the company, industry, securities or developments referred to in the material. Any forecasts contained in this report were independently prepared unless otherwise stated and HAVE NOT BEEN endorsed by the Management of the company which is the subject of this report. Additional information is available upon request. THIS REPORT IS COPYRIGHT. YOU MAY NOT REDISTRIBUTE THIS REPORT WITHOUT OUR PERMISSION. Please give proper credit, including citing Fundamental Research Corp and/or the analyst, when quoting information from this report. The information contained in this report is intended to be viewed only in jurisdictions where it may be legally viewed and is not intended for use by any person or entity in any jurisdiction where such use would be contrary to local regulations or which would require any registration requirement within such jurisdiction.
Premiumization Gains Traction as Global Smartwatch Shipments Contract
Paused · 9:43 left · FRC · read by an AI voice
Discussion
Comments reflect the views of individual users, not FRC. Nothing posted in the comments section — by users or otherwise — should be taken as investment advice.